QIM
LAB icon

Quantitative Investment Management’s Standard BioTools LAB Stock Holding History

Quantitative Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-73,300
Closed -$293K – 523
2020
Q2 		$293K Buy
+73,300
New +$255K 0.03% 417
2015
Q4 		– Sell
-25,000
Closed -$202K – 778
2015
Q3 		$202K Buy
+25,000
New +$394K 0.02% 605

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantitative Investment Management's LAB Position: Q3 2020 in Review

Quantitative Investment Management sold out of Standard BioTools (LAB) in Q3 2020, closing a stake of 73,300 shares — an estimated $293K sold.

Quantitative Investment Management first reported a position in LAB in Q3 2015 and held it in 2 quarters. The position peaked at $293K in Q2 2020. 134 funds tracked by Wall St. Rank hold LAB as of Q3 2020.

  • Quantitative Investment Management reported no remaining Standard BioTools position as of Q3 2020 after selling out during the quarter.
  • Quantitative Investment Management sold 73,300 Standard BioTools shares in Q3 2020, an estimated $293K.
  • Quantitative Investment Management first reported a position in Standard BioTools in Q3 2015 and held it in 2 quarters.
  • Quantitative Investment Management's Standard BioTools position peaked at $293K in Q2 2020.
  • 134 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2020.

Based on Quantitative Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.